The Homeopathic Pharmacopoeia of the United States
By Mark Land, AAHP president June 1, 2017 The Homeopathic Pharmacopoeia of the United States (HPUS) is the legal basis for marketing homeopathic drug products in the United States and…
Read More2017 Updates in the Homeopathic Pharmacopeia
By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Before proceeding to review the major areas of updates in the HPUS, two specific items are of timely interest:…
Read MoreDelivering Key Messages
By Alissa Gould, public relations manager, Boiron USA June 1, 2017 Building on April and May 2017 articles on preparing for important communications and developing key messages, this article will…
Read MoreDeveloping Key Messages
By Alissa Gould, public relations manager, Boiron USA May 1, 2017 Last month (April 2017), I shared an article on being prepared and asking the right questions for media interviews…
Read MoreHomeopathic Manufacturers Explore Next-Generation Quality Control
MILWAUKIE, Ore., May 4, 2017 — Member companies of the American Association of Homeopathic Pharmacists (AAHP) gathered to learn about promising new technologies recently used by the U.S. Food and…
Read MoreDisclaimers in Advertising and Labeling: What Do They Do? Who Does What?
By Mark Land, AAHP President The FTC has long recognized that marketing claims may include additional explanatory information to prevent the claims from being misleading. This is FTC’s way of…
Read MoreUnited States Food and Drug Administration Office of Pharmaceutical Quality
By Mark Land, AAHP President May 1, 2017 The Office of Pharmaceutical Quality (OPQ), created in Jan. 2015, enhances the U.S. Food and Drug Administration Center for Drug Evaluation and…
Read MoreAAHP Recognized as Voice of Homeopathy on Capitol Hill
MILWAUKIE, Ore., Apr. 10, 2017 — The American Association of Homeopathic Pharmacists’ (AAHP) Legal & Regulatory Committee recently received the 2017 Henry N. Williams Professional Service Award from the National…
Read MoreBe Prepared: Media Basics for the Non-PR Expert
By Alissa Gould, public relations manager, Boiron USA April 1, 2017 As more people discover the benefits of homeopathic medicines, our industry may become a larger target for skeptics or…
Read MoreFDA Office of Surveillance and Epidemiology
By Mark Land, AAHP President April 1, 2017 FDA’s Office of Surveillance and Epidemiology (OSE) is positioned within the Center for Drug Evaluation and Research (CDER). OSE evaluates the safety…
Read More